Psychiatr. praxi. 2011;12(4):140-144 [Neurol. praxi. 2011;12(2):98-103]

Mood and behaviour disorder in dementias

MUDr.Pavel Ressner, Ph.D., MUDr.Petra Bártová, Ph.D., Mgr.Petr Nilius, Mgr.Dagmar Beránková, Mgr.Petra Szajterová, MUDr.Michal Bar, Ph.D., doc.MUDr.David Školoudík, Ph.D.
Kognitivní centrum, Neurologická klinika FN Ostrava

According to various sources in the literature, dementia is caused by Alzheimer’s dementia in approximately 50–60 %, vascular dementia in

10 % and dementia with Lewy bodies in 15–20 %. In addition to these untreatable or difficult-to-treat conditions, there are causes of dementias

which are reversible and these account for about 10 % of dementias. Cognitive disorder is the main symptom in all aetiologies of dementias;

however, the risk of patient institutionalization is rather dependent on the severity of noncognitive disorders in dementia syndromes, i. e.

behavioural and psychological symptoms in dementia (BPSD). BPSD represent a major burden for caregivers and inadequate BPSD treatment

increases the likelihood of failure of the caregiver and of the entire background of the patient. The article presents an overview of

BPSD, the methods of examining noncognitive disorders and the treatment options. It aims to be a practical guide for the physician caring

for patients with dementia and outlines the topics and aspects that should be remembered when caring for these patients.

Keywords: dementia, behavioural disorder, mental disorder, Alzheimer’s disease, dementia treatment

Published: October 22, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ressner P, Bártová P, Nilius P, Beránková D, Szajterová P, Bar M, Školoudík D. Mood and behaviour disorder in dementias. Psychiatr. praxi. 2011;12(4):140-144.
Download citation

References

  1. Ballard CG, Margallo-Lana M, Fossey J, Reichelt K, Myint P, Potkins D, O'Brien J. A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. J Clin Psychiatry 2001; 62(8): 631-636. Go to original source... Go to PubMed...
  2. Bartoš A, Martínek P, Buček A, Řípová D. Dotazník soběstačnosti DAD-CZ - česká verze pro hodnocení každodenních aktivit pacientů s Alzheimerovou nemocí. Neurol. Praxi 2009; 10(5): 320-323.
  3. Bowden PD. Use of selective serotonin reuptake inhibitors in the treatment of depression in older adults: identifying and managing potential risk for hyponatremia. Geraitr Nurs 2009; 30(2): 84-89. Go to original source...
  4. Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson´s disease. Mov Disord 2006; 21(11): 1899-1907. Go to original source... Go to PubMed...
  5. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornmein J. The neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314. Go to original source... Go to PubMed...
  6. Deudon A, Maubourget N, Gervais X, et al. Nonpharmacological management of behavioral symptoms in nursing homes. Int J Geriatr Psychiatry 2009; 24: 1386-1395. Go to original source... Go to PubMed...
  7. Jirák R, Koukolík F. Demence. Galén, Praha, 2002: 335.
  8. Kaup BA, Loreck D, Gruber-Baldini AL, German P, Menon AS, Zimmerman S, Burton L, Magaziner J. Depression and its relationship to function and medical status, by dementia status, in nursing home admissions. Am J Geriatr Psychiatry 2007; 15(5): 438-442. Go to original source... Go to PubMed...
  9. Lovestone S, Gauthier S. Management of Dementia, Martin Dunitz Ltd., London 2001: 168. Go to original source...
  10. Parnetti L, Amici S, Lanari A, Gallai V. Pharmacological treatment of non-cognitive disturbances in dementi disorders. Mech-Ageing-Dev 2001; 122(16): 2063-2069. Go to original source... Go to PubMed...
  11. Ravi S. Cognitive rehabilitation for reversible and progressive brain injury. Indian J Psychiatry 2008; 50(4): 282-284. Go to original source... Go to PubMed...
  12. Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V, Sheardová K. Doporučené postupy pro diagnostiku Alzheimerovy nemoci a ostatních demencí. Neurol. Praxi 2009; 10(4): 237-241.
  13. Ressner P, Kaňovský P. Demence - diferenciální diagnóza, diagnostické metody, léčba. Neurol. Praxi 2006; 9(Suppl D): 1-38.
  14. Rösler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int Clin Pract Suppl 2002; (127): 20-36.
  15. Sheardová K, Hort J, Rusina R, B\rtoš A, Línek V, Ressner P, Rektorová I. Doporučené postupy pro léčbu Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Čes. slov. neurol N. 2007; 70/103(5): 253-258.
  16. Smolík P. Duševní a behaviorální poruchy. Maxdorf, Praha 1996: 504.
  17. Snowden M, Sato K, Roy-Byrne P. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature. J Am Geriatr Soc 2003; 51(9): 1305-1317. Go to original source... Go to PubMed...
  18. Starkstein SE, Mizrahi R. Depression in Alzheimer´s disease. Expert Rev Neuroether 2006; 6(6): 887-895. Go to original source... Go to PubMed...
  19. Takai M, Takahashi M, Iwamitsu Y, Ando N, Okazaki S, Nakajima K, Oishi S, Miyaoka H. The experience of burnout among caregivers of patients with dementia: relations to depression and quality of life. Arch Gerontol Geriatr 2009; 49(1): e1-5. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.